0
View
Open Access Peer-Reviewed|
Artigo Original

Assessment of survival in patients with cervical cancer in a hospital based cohort in Southern Brazil

Sobrevida de mulheres com câncer de colo uterino em um centro de referência do sul do Brasil

Rafael José Vargas Alves1,8; Guilherme Watte2; Anderson da Silva Garcez3; António Armando4; Neiro Waechter da Motta5,6; Alice de Medeiros Zelmanowicz7, 8

DOI: 10.26790/BJO20171346A74

ABSTRACT

OBJECTIVE: To evaluate the overall survival of women with cervical cancer in a reference service in the South of Brazil.
METHODS: This retrospective cohort study was carried out at Santa Rita Hospital (Porto Alegre, Brazil) with women diagnosed with cervical cancer between 2005 and 2006. We analysed data from all patients with cervical cancer (ICD 10: C53) included in the hospital cancer register. Incidence and mortality data were collected on March 1st 2013. Variables such as age, stage and treatment type were used in the overall survival analysis. Mortality data were compared with the NIS/DAT/CEVS/SES/RS database.
RESULTS: A total of 269 analytical cases that had complete information on cancer staging were assessed between 2005 and 2006. The mean age was of 50 years old (SD= ±13); 71% were stage II-III in the beginning of the treatment. Epidermoid carcinoma was the most common histology (90%). By March 2013, 110 women (40.8%) died. The five-year survival rate decreased as the level of staging showing 83%, 74%, 51% e 23% for stages I, II, III, and IV, respectively.
CONCLUSION: Overall survival rate of cervical cancer patients was of 67. These results are similar to data from developed countries.

Keywords: Uterine cervical neoplasms; Early detection of cancer; Delayed diagnosis; Survival analysis

RESUMO

OBJETIVO: Avaliar a sobrevida global de mulheres com câncer de colo do útero (CCU) em um serviço de referência do sul do Brasil.
MÉTODOS: Estudo de coorte retrospectivo, realizado no Hospital Santa Rita (Porto Alegre/RS) com mulheres com diagnóstico de CCU entre 2005 e 2006. Os dados foram do registro de câncer coletados de todas as pacientes com CCU (CID 10: C53). Os dados referentes à incidência e a mortalidade foram coletados em 01/03/2013. As variáveis idade, estadiamento e tipo de tratamento foram utilizadas na análise de sobrevida. Os dados de mortalidade foram comparados com o banco de dados do NIS/DAT/CEVS/SES/RS.
RESULTADOS: No período entre 2005-2006, um total de 269 casos analíticos foram analisados que tinham informaçoes de estadiamento completo. A média de idade foi 50 ± 13 anos, 71% apresentavam estadiamento II-III no início do tratamento. Carcinoma epidermóide foi a histologia mais prevalente (90%). Até março de 2013, 110 mulheres (40,8%) foram a óbito e a sobrevida global em 5 anos foi de 67% (IC 95%: 62-71%). A sobrevida global em 5 anos diminuiu conforme o nível de estadiamento sendo de 83%, 74%, 51% e 23% para os estágios I, II, III e IV, respectivamente.
CONCLUSAO: A sobrevida geral das pacientes com CCU foi de 67%. Esses resultados sao semelhantes aos dados de países desenvolvidos.

Palavras-chave: Neoplasias do colo do útero; Detecçao precoce de câncer; Diagnóstico tardio; Análise de sobrevida


THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS FORMAT.


Creative Commons License
This work is licensed under an Attribution 4.0 International License (CC BY 4.0), effective June 9, 2022. Previously, the journal was licensed under a Creative Commons Attribution - Non-Commercial - Share Alike 4.0 International License.

Site Map



  • SPONSORED BY

© All rights reserved 2024 - Brazilian Journal Of Oncology